Ampio Pharmaceuticals, Inc. (AMPE)

Ampio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cost of Revenue	0.25	2.08	1.09	1.18	1.27
Gross Profit	-0.25	-2.08	-1.09	-1.18	-1.27
Selling, General & Admin	6.95	11.47	8.67	6.65	5.9
Research & Development	2.32	8.92	11.9	9.17	12.62
Other Operating Expenses	0.06	1.94	0	0.01	0.06
Operating Expenses	9.27	20.38	20.57	15.83	18.58
Operating Income	-9.52	-24.21	-25.16	-15.22	-23.45
Interest Income	0.35	0.22	0	0.01	0.08
Interest Expense	0	-7.87	0	0	0.08
Other Expense / Income	-0.54	0.22	-8.08	0.69	-9.82
Pretax Income	-8.63	-16.34	-17.08	-15.89	-13.63
Income Tax	0	-7.87	-4.59	0.6	-4.95
Net Income	-8.63	-8.47	-12.49	-16.5	-8.68
Shares Outstanding (Basic)	1	1	1	1	0
Shares Outstanding (Diluted)	1	1	1	1	0
Shares Change	7.50%	12.23%	12.78%	25.61%	23.29%
EPS (Basic)	-10.66	-11.24	-18.79	-28.63	-18.32
EPS (Diluted)	-10.66	-11.24	-18.59	-27.71	-18.32
Free Cash Flow	-8.56	-21.13	-14.19	-14.79	-15.41
Free Cash Flow Per Share	-10.57	-28.04	-21.13	-24.84	-32.50
EBITDA	-9.27	-23.16	-24.06	-14.04	-22.17
Depreciation & Amortization	0.25	1.05	1.09	1.18	1.27
EBIT	-9.52	-24.21	-25.16	-15.22	-23.45

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.